Menu
03 Mar 2026

Latham & Watkins Advises Underwriter on BrightSpring’s $823M Secondary Offering by KKR and Management

"Latham & Watkins advised the underwriter on an underwritten secondary offering by certain BrightSpring stockholders — including an affiliate of KKR and some members of management — of 20,000,000 BrightSpring common shares at $41.15 per share. No shares were sold by BrightSpring and the selling stockholders will receive all proceeds; the offering is expected to close March 4, 2026. The Latham Capital Markets team was led by partners Marc Jaffe, Ian Schuman and Kaj Nielsen."

Latham & Watkins LLP represented the underwriter in the offering by certain selling stockholders (including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of BrightSpring management). The transaction was an underwritten secondary offering of 20,000,000 shares of BrightSpring Health Services, Inc. common stock at a public offering price of US$41.15 per share. No shares were sold by BrightSpring; the selling stockholders will receive all proceeds. The offering was expected to close on March 4, 2026, subject to customary closing conditions. Participating Latham lawyers (seniority and practice area as described in the release): - Marc Jaffe — partner, Capital Markets - Ian Schuman — partner, Capital Markets - Kaj Nielsen — partner, Capital Markets - Molly Mitchell — associate, Capital Markets - Nicole Liffrig Molife — counsel, Healthcare - Margaret Rote — associate, Healthcare - Elena Romanova — partner, Tax - Jack Santoro — associate, Tax
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.